ImmunityBio, Inc. Profile Avatar - Palmy Investing

ImmunityBio, Inc.

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulato…

Biotechnology
US, San Diego [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

ImmunityBio, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

ImmunityBio, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of ImmunityBio, Inc..

End of IBRX's Analysis
CIK: 1326110 CUSIP: 45256X103 ISIN: US45256X1037 LEI: - UEI: -
Secondary Listings
IBRX has no secondary listings inside our databases.